Gillian Ellsbury

528 total citations
19 papers, 141 citations indexed

About

Gillian Ellsbury is a scholar working on Epidemiology, Emergency Medicine and Infectious Diseases. According to data from OpenAlex, Gillian Ellsbury has authored 19 papers receiving a total of 141 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 9 papers in Emergency Medicine and 2 papers in Infectious Diseases. Recurrent topics in Gillian Ellsbury's work include Pneumonia and Respiratory Infections (12 papers), Emergency and Acute Care Studies (9 papers) and Respiratory viral infections research (7 papers). Gillian Ellsbury is often cited by papers focused on Pneumonia and Respiratory Infections (12 papers), Emergency and Acute Care Studies (9 papers) and Respiratory viral infections research (7 papers). Gillian Ellsbury collaborates with scholars based in United Kingdom, Australia and United States. Gillian Ellsbury's co-authors include Andrew Vyse, James Campling, Mary Slack, Diana Mendes, Harish Madhava, Tendai Mugwagwa, Dylan Jones, James D. Chalmers, Qin Jiang and Carole Czudek and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Vaccine.

In The Last Decade

Gillian Ellsbury

17 papers receiving 141 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gillian Ellsbury United Kingdom 7 122 30 26 14 12 19 141
James Campling United Kingdom 8 177 1.5× 41 1.4× 27 1.0× 11 0.8× 9 0.8× 20 196
Gertjan H.J. Wagenvoort Netherlands 7 171 1.4× 21 0.7× 59 2.3× 7 0.5× 7 0.6× 13 190
Abián Montesdeoca Melián Spain 9 89 0.7× 14 0.5× 38 1.5× 6 0.4× 27 2.3× 16 129
Annick Robinson Madagascar 7 60 0.5× 13 0.4× 21 0.8× 9 0.6× 6 0.5× 18 110
Mélina Messaoudi France 6 149 1.2× 10 0.3× 33 1.3× 5 0.4× 3 0.3× 11 180
Ana María Gómez Álvarez Chile 3 178 1.5× 33 1.1× 97 3.7× 7 0.5× 13 1.1× 12 254
Matt Thomas United Kingdom 4 58 0.5× 8 0.3× 17 0.7× 11 0.8× 6 0.5× 6 83
Maya Dunstan United States 5 119 1.0× 23 0.8× 43 1.7× 1 0.1× 14 1.2× 5 173
Azwifarwi Mathunjwa United States 7 50 0.4× 5 0.2× 9 0.3× 12 0.9× 15 1.3× 9 106
Tahreni Bwanaali United Kingdom 4 170 1.4× 9 0.3× 63 2.4× 5 0.4× 35 2.9× 4 193

Countries citing papers authored by Gillian Ellsbury

Since Specialization
Citations

This map shows the geographic impact of Gillian Ellsbury's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gillian Ellsbury with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gillian Ellsbury more than expected).

Fields of papers citing papers by Gillian Ellsbury

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gillian Ellsbury. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gillian Ellsbury. The network helps show where Gillian Ellsbury may publish in the future.

Co-authorship network of co-authors of Gillian Ellsbury

This figure shows the co-authorship network connecting the top 25 collaborators of Gillian Ellsbury. A scholar is included among the top collaborators of Gillian Ellsbury based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gillian Ellsbury. Gillian Ellsbury is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Reynard, Charles, James Campling, Adam Gordon, et al.. (2024). Adult risk groups for vaccine preventable respiratory infections: an overview of the UK environment. Expert Review of Vaccines. 23(1). 1052–1067. 1 indexed citations
2.
Mendes, Diana, Mark Atwood, Reiko Sato, et al.. (2023). OP78 Cost-effectiveness Of A 20-valent Pneumococcal Conjugate Vaccine To Directly Protect Adults Against Pneumococcal Disease In England. International Journal of Technology Assessment in Health Care. 39(S1). S20–S21.
3.
Wilson, Michele, A. O. Lucas, Diana Mendes, et al.. (2023). Estimating the Cost-Effectiveness of Switching to Higher-Valency Pediatric Pneumococcal Conjugate Vaccines in the United Kingdom. Vaccines. 11(7). 1168–1168. 18 indexed citations
4.
Graham, H. Kerr, Andrew Vyse, Charles Reynard, et al.. (2023). P153 Adult respiratory illness attendances to emergency departments: the pinnacle of winter pressures. A200.1–A200.
5.
Campling, James, Andrew Vyse, Mary Slack, et al.. (2023). A review of evidence for pneumococcal vaccination in adults at increased risk of pneumococcal disease: risk group definitions and optimization of vaccination coverage in the United Kingdom. Expert Review of Vaccines. 22(1). 785–800. 16 indexed citations
6.
Hyams, Catherine, George Nava, Robert Challen, et al.. (2023). Impact of SARS-CoV-2 infective exacerbation of chronic obstructive pulmonary disease on clinical outcomes in a prospective cohort study of hospitalised adults. Journal of the Royal Society of Medicine. 116(11). 371–385. 8 indexed citations
7.
Campling, James, Elizabeth Begier, Andrew Vyse, et al.. (2022). A novel approach to estimate the local population denominator to calculate disease incidence for hospital-based health events in England. Epidemiology and Infection. 150. e150–e150. 2 indexed citations
8.
Campling, James, Gillian C. Hall, Tendai Mugwagwa, et al.. (2022). Hospitalization costs of adult community-acquired pneumonia in England. Journal of Medical Economics. 25(1). 912–918. 15 indexed citations
9.
Mendes, Diana, Mark Atwood, Reiko Sato, et al.. (2022). Cost-effectiveness of using a 20-valent pneumococcal conjugate vaccine to directly protect adults in England at elevated risk of pneumococcal disease. Expert Review of Pharmacoeconomics & Outcomes Research. 22(8). 1285–1295. 23 indexed citations
10.
Mugwagwa, Tendai, Mark Atwood, Reiko Sato, et al.. (2022). Public health and budgetary impact of 20-valent pneumococcal conjugate vaccine for adults in England. Expert Review of Vaccines. 21(9). 1331–1341. 4 indexed citations
11.
Vyse, Andrew, James Campling, Carole Czudek, et al.. (2021). A review of current data to support decision making for introduction of next generation higher valency pneumococcal conjugate vaccination of immunocompetent older adults in the UK. Expert Review of Vaccines. 20(10). 1311–1325. 6 indexed citations
12.
Holding, Maya, Heinz‐Josef Schmitt, & Gillian Ellsbury. (2021). TBE in United Kingdom. 1 indexed citations
13.
Campling, James, Elizabeth Begier, Andrew Vyse, et al.. (2021). A novel approach to calculate disease incidence for hospital-based health events in England. The Lancet. 398. S30–S30. 1 indexed citations
14.
Ellsbury, Gillian, James Campling, Harish Madhava, & Mary Slack. (2021). Identifying UK travellers at increased risk of developing pneumococcal infection: a novel algorithm. Journal of Travel Medicine. 28(6). 1 indexed citations
15.
16.
Campling, James, Dylan Jones, James D. Chalmers, et al.. (2020). Clinical and financial burden of hospitalised community-acquired pneumonia in patients with selected underlying comorbidities in England. BMJ Open Respiratory Research. 7(1). e000703–e000703. 16 indexed citations
17.
Campling, James, Dylan Jones, James D. Chalmers, et al.. (2019). The impact of certain underlying comorbidities on the risk of developing hospitalised pneumonia in England. SHILAP Revista de lepidopterología. 11(1). 4–4. 19 indexed citations
18.
Vyse, Andrew, Gillian Ellsbury, & Harish Madhava. (2018). Protecting UK adolescents and adults against meningococcal serogroup B disease. Expert Review of Vaccines. 17(3). 229–237. 5 indexed citations
19.
Campling, James, Dylan Jones, Gillian Ellsbury, et al.. (2017). S6 Establishing the true incidence of hospitalised community acquired pneumonia (cap) in the uk: a hospital episode statistics (hes) analysis. HighWire Press Open Archive. A7–A7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James Campling Breakdown of academic impact, for papers by Gertjan H.J. Wagenvoort Breakdown of academic impact, for papers by Abián Montesdeoca Melián Breakdown of academic impact, for papers by Annick Robinson Breakdown of academic impact, for papers by Mélina Messaoudi Breakdown of academic impact, for papers by Ana María Gómez Álvarez Breakdown of academic impact, for papers by Matt Thomas Breakdown of academic impact, for papers by Maya Dunstan Breakdown of academic impact, for papers by Azwifarwi Mathunjwa Breakdown of academic impact, for papers by Tahreni Bwanaali
Rankless by CCL
2026